Featured Research

from universities, journals, and other organizations

Increased bodyweight after stopping smoking may be due to changes in insulin secretion

Date:
May 7, 2012
Source:
European Society of Endocrinology
Summary:
Fear of putting on weight is one of the major reasons why smokers do not give up their habit. The reasons for this weight gain are believed to be in part due to metabolic changes in the body, but until now precise details of these changes were not known. New work had shown that changes in insulin secretion could be related to weight gain after smoking cessation.

Fear of putting on weight is one of the major reasons why smokers do not give up their habit. The reasons for this weight gain are believed to be in part due to metabolic changes in the body, but until now precise details of these changes were not known. On May 8, 2012, however, a researcher from Austria told delegates at the International Congress of Endocrinology/European Congress of Endocrinology that her work had shown that changes in insulin secretion could be related to weight gain after smoking cessation.

Dr. Marietta Stadler, from the Hietzing Hospital in Vienna, Austria, enrolled healthy smokers on a smoking cessation programme into a study in which they underwent three-hour oral glucose tolerance tests (OGTT) while still smoking and after a minimum of three and six months after giving up. Their body composition was also measured at the same time. The researchers measured beta cell [1] secretion of insulin both while fasting and after exposure to glucose, and also looked at appetite levels in the participants by offering them a free choice buffet meal. In addition to insulin, fasting levels of a number of hormones involved in regulating energy intake and appetite were measured.

"We found that body weight and fat mass increased after three months of no smoking, by 4% and 22% respectively," said Dr. Stadler, "and after six months the increase was 5% and 35% respectively. The most striking metabolic findings were an increased first phase insulin secretion in response to glucose challenge, as well as increased carbohydrate intake in the free choice buffet after three months of non-smoking. Participants showed significant fasting insulin resistance, where the normal response to a given amount of insulin is reduced, at three months, but not at six months, while dynamic insulin sensitivity (the sensitivity to insulin in the postprandial state) assessed during the OGTT remained unchanged throughout. Neuropeptide-Y (NPY) [2] levels at fasting were increased at three months, but not at six months.

"We believe that the alterations in insulin secretion could possibly be related to the increased carbohydrate cravings and weight gain experienced by many smokers who give up. However, the increase in insulin secretion and carbohydrate intake seems to be a transient effect of stopping smoking, as these changes were not seen any more after six months, even though the participants had gained more weight."

Increased insulin secretion at three months was less pronounced in those who finally succeeded in quitting smoking for at least six months, as opposed to those who relapsed after three months. "All these factors are pointers to understanding the metabolic processes involved in weight gain after smoking cessation," said Dr. Stadler. "The more we can understand the biological basis for the phenomenon, the higher our chances of being able to control it."

The researchers now intend to match a group of non-smokers of the same age and body mass with the participants of this study in order to see whether, in comparison to non-smokers, beta cell function is altered in those who are still smoking and not just during the period when they are quitting.

"We also intend to discuss our results with experts in the field of addiction and behavioural medicine in order to gather ideas and hypotheses as to why smoking might exert these metabolic effects, in order that we can plan studies that bring together the many disciplines involved in this important field of research," Dr. Stadler concluded.


Story Source:

The above story is based on materials provided by European Society of Endocrinology. Note: Materials may be edited for content and length.


Cite This Page:

European Society of Endocrinology. "Increased bodyweight after stopping smoking may be due to changes in insulin secretion." ScienceDaily. ScienceDaily, 7 May 2012. <www.sciencedaily.com/releases/2012/05/120507210042.htm>.
European Society of Endocrinology. (2012, May 7). Increased bodyweight after stopping smoking may be due to changes in insulin secretion. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/05/120507210042.htm
European Society of Endocrinology. "Increased bodyweight after stopping smoking may be due to changes in insulin secretion." ScienceDaily. www.sciencedaily.com/releases/2012/05/120507210042.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins